Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthostatic blood pressure reduction is associated with renal damage in functionally preserved elderly hypertensive patients.

Nefrologia·2026
Same author

Gene-disease relationships for glomerular phenotypes: expert recommendations from ClinGen.

Nature reviews. Nephrology·2026
Same author

Machine Learning Prediction of Transthyretin Binding for Thyroid Hormone Transport Disruption for Chemical Risk Assessment.

Toxics·2026
Same author

Evaluation of Urinary Tubular Biomarkers in Dogs with Myxomatous Mitral Valve Disease Across ACVIM Stages.

Veterinary sciences·2026
Same author

Unravelling sex-specific differences in autosomal dominant polycystic kidney disease: a multiorgan perspective.

Clinical kidney journal·2026
Same author

Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints.

Genes·2026

Related Experiment Video

Updated: Feb 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

949

MYH9 Associated nephropathy.

Mónica Furlano1, Rosa Arlandis2, María Del Prado Venegas3

  • 1Enfermedades Renales Hereditarias, Servicio de Nefrología, Fundació Puigvert, Barcelona, España; Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, España; Departamento de Medicina, Universidad Autònoma de Barcelona, REDinREN, Instituto de Investigación Carlos III, Barcelona, España.

Nefrologia
|November 26, 2018
PubMed
Summary
This summary is machine-generated.

MYH9 related diseases, caused by MYH9 gene mutations, are rare genetic disorders. Genetic testing is crucial for diagnosing these conditions, which affect kidney function, hearing, and vision.

Keywords:
Alport syndromeAnomalía de May-HegglinEpstein syndromeHearing lossHipoacusiaMYH9 nephropathyMay-Hegglin anomalyNefropatía MYH9Sindrome de SebastiánSíndrome de AlportSíndrome de EpsteinThrombocytopeniaTrombocitopenia

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

964

Related Experiment Videos

Last Updated: Feb 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

949
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

964

Area of Science:

  • Genetics
  • Nephrology
  • Hematology

Background:

  • MYH9 gene mutations cause rare autosomal dominant disorders.
  • The MYH9 gene encodes nonmuscle myosin heavy chain IIA, vital in podocytes and mesangial cells.
  • These disorders manifest as macrothrombocytopenia, leukocyte inclusions, and risks of renal failure, hearing loss, and cataracts.

Observation:

  • A 27-year-old woman initially diagnosed with idiopathic thrombocytopenic purpura.
  • Subsequent development of renal involvement and hearing loss prompted further investigation.
  • Detailed family history and genetic testing confirmed a diagnosis of MYH9-related nephropathy.

Findings:

  • Genetic testing confirmed the diagnosis of nephropathy associated with MYH9 mutation.
  • The case highlights diagnostic challenges in rare genetic diseases.
  • Delayed diagnosis can occur despite initial presentation with common hematological findings.

Implications:

  • This case underscores the importance of genetic testing for diagnosing rare MYH9-related disorders.
  • Early and accurate diagnosis can potentially improve patient outcomes.
  • Increased awareness among clinicians is vital for timely identification and management.